TRINITY BIOTECH PLC (TRIB) Free cash flow 2015–2024
TRINITY BIOTECH PLC (TRIB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.6MFY2024 · since FY2015: $6.1M → -$4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.6M | +62.8% |
| FY2023 | -$12.4M | -511.3% |
| FY2022 | -$2.0M | -117.7% |
| FY2021 | $11.4M | -44.5% |
| FY2020 | $20.6M | +523.7% |
| FY2019 | $3.3M | +1203.3% |
| FY2018 | -$299,000 | -106.8% |
| FY2017 | $4.4M | -26.6% |
| FY2016 | $6.0M | -0.8% |
| FY2015 | $6.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRIB financial trends
TRIB RevenueTRIB Net incomeTRIB Net marginTRIB Gross profitTRIB Gross marginTRIB Operating incomeTRIB Operating marginTRIB Operating cash flowTRIB Capital expendituresTRIB Return on equityTRIB Stock buybacksTRIB Dividends paidTRIB Total assetsTRIB Total liabilitiesTRIB Shareholders’ equityTRIB overview →